Provectus Biopharma (PVCT) Reports Q2 Loss of $0.02/Share

August 11, 2016 9:29 AM EDT
Get Alerts PVCT Hot Sheet
Price: $0.01 --0%

Financial Fact:
Total operating loss: -5.78M

Today's EPS Names:
HOV, CHKE, GTIM, More
Trade PVCT Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Provectus Biopharma (NYSE: PVCT) reported Q2 EPS of ($0.02), versus ($0.02) reported last year.

Our cash and cash equivalents were $4,891,313 at June 30, 2016, compared with $9,760,997 at March 31, 2016.

For earnings history and earnings-related data on Provectus Biopharma (PVCT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment